A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : tPA

Search Conditions:
Search Keyword : tPA
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: tPA
Appearance Frequency: 7894 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tissue plasminogen activator
(7662 times)
Vascular Diseases
(1875 times)
PAI-1 (1411 times)
uPA (593 times)
PAI (336 times)
1978 Inhibition of plasminogen activator production in organ cultures by cycloheximide.
tissue-type PA
(163 times)
Vascular Diseases
(20 times)
uPA (98 times)
PA (91 times)
PAs (46 times)
1985 Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages.
tissue PA
(25 times)
Neoplasms
(4 times)
uPA (15 times)
PA (13 times)
PAs (8 times)
1984 Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.
trans-parinaric acid
(12 times)
Colloids
(5 times)
DPH (5 times)
POPC (4 times)
DPPC (3 times)
1986 Endotoxin protects against hyperoxic decrease in membrane fluidity in endothelial cells but not in fibroblasts.
tissue Plg activator
(8 times)
Biochemistry
(3 times)
Pg (3 times)
PLG (3 times)
uPA (3 times)
1992 Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
tissue recombinant plasminogen activator
(2 times)
Neurology
(2 times)
--- 2006 Sonothrombolysis: experimental evidence.
trans-palmitoleic acid
(2 times)
Biochemistry
(1 time)
EA (2 times)
TVA (2 times)
F2-IsoP (1 time)
2017 Trans Fatty Acids Suppress TNF-alpha-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells.
TTPeak
(2 times)
Vascular Diseases
(1 time)
rFVIIa (1 time)
2011 Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.
types of plasminogen activators, tissue type
(2 times)
Endocrinology
(1 time)
uPA (2 times)
PAI-1 (1 time)
1993 The plasminogen activator and inhibitor system in bone remodelling.
10  components, plasminogen activator
(1 time)
General Surgery
(1 time)
CM (1 time)
EC (1 time)
HUV (1 time)
1993 Ambient oxygen tension modulates endothelial fibrinolysis.
11  long-term functional outcome for patients who receive intravenous alteplase
(1 time)
Health Services
(1 time)
DTN (1 time)
mRS (1 time)
MUSC (1 time)
2018 Long-Term Functional Outcome of Telestroke Patients Treated Under Drip-and-Stay Paradigm Compared with Patients Treated in a Comprehensive Stroke Center: A Single Center Experience.
12  parameters-tissue plasminogen activator
(1 time)
Transplantation
(1 time)
CAD (1 time)
hsCRP (1 time)
ICAM (1 time)
2008 Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.
13  tert-pentyl acrylamide
(1 time)
Chemistry Techniques, Analytical
(1 time)
LB (1 time)
2005 Molecular orientation of azobenzene chromophores in ultrathin polymer nanosheets studied by attenuated total reflection spectroscopy.
14  therapeutic
(1 time)
Biological Science Disciplines
(1 time)
MCA (1 time)
2011 Modeling stroke in mice - middle cerebral artery occlusion with the filament model.
15  therapy was unavailability of alteplase
(1 time)
Vascular Diseases
(1 time)
--- 2018 Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke.
16  therapy with alteplase
(1 time)
Vascular Diseases
(1 time)
--- 2015 Endovascular thrombolysis to salvage central venous access in children with catheter-associated upper extremity deep vein thrombosis: technique and initial results.
17  thrombin inhibition by PAI-1 2.5-fold and of thrombin-VR1
(1 time)
Molecular Biology
(1 time)
PAI-1 (1 time)
1999 The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
18  thrombolysis with alteplase
(1 time)
Neurology
(1 time)
DWI (1 time)
FLAIR (1 time)
MRI (1 time)
2012 [EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke].
19  Tissue plasminogen inhibitor
(1 time)
Hematology
(1 time)
CRP (1 time)
ERalpha (1 time)
ERbeta (1 time)
2010 Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens.
20  total PA, and tissue PA
(1 time)
Reproductive Medicine
(1 time)
PA (1 time)
uPA (1 time)
2004 [How chronic prostatitis affects plasminogen activator system].
21  transfected with pSVtPA
(1 time)
Vascular Diseases
(1 time)
UK (1 time)
1993 High-level expression of antibody-plasminogen activator fusion proteins in hybridoma cells.
22  transfected with these constructs, pSVtPA
(1 time)
Vascular Diseases
(1 time)
UK (1 time)
1993 High-level expression of antibody-plasminogen activator fusion proteins in hybridoma cells.
23  treatment and cost of administration of alteplase
(1 time)
Vascular Diseases
(1 time)
MI (1 time)
r-PA (1 time)
2000 Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA.
24  treatment for ischemic stroke is intravenous administration of plasminogen activator
(1 time)
Medicine
(1 time)
--- 2013 Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation.
25  trials of alteplase
(1 time)
Medicine
(1 time)
--- 2016 Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis.